二氢青蒿素下调粒系白血病细胞转铁蛋白受体表达

被引:7
作者
王增
周慧君
机构
[1] 浙江大学药学院
基金
浙江省自然科学基金;
关键词
二氢青蒿素; 转铁蛋白受体; K562细胞; HL60细胞; 铁饱和转铁蛋白;
D O I
10.16438/j.0513-4870.2008.06.003
中图分类号
R285 [中药药理学];
学科分类号
1008 ;
摘要
通过建立常铁HL60和K562细胞以及富铁K562细胞体外模型,研究二氢青蒿素对粒系白血病细胞转铁蛋白受体(transferrin receptor,TfR)的调控作用。采用流式细胞术检测二氢青蒿素对粒系白血病细胞TfR密度的调控作用,Western blotting和RT-PCR法检测二氢青蒿素对粒系白血病细胞TfR表达的调控作用,原子吸收分光光度法检测二氢青蒿素对常铁和富铁K562细胞铁含量的影响,以及MTT法和台盼蓝拒染法分析二氢青蒿素对粒系白血病细胞增殖的作用。结果显示,二氢青蒿素能显著降低常铁HL60和K562细胞TfR的密度和下调TfR蛋白的表达,且呈浓度和时间依赖性,并能有效地抑制细胞增殖,IC50值分别为1.74和11.33μmol.L-1。二氢青蒿素对富铁K562细胞的TfR蛋白和mRNA表达能进一步增强下调作用,与常铁培养组比较,10μmol.L-1二氢青蒿素对富铁K562细胞TfR蛋白和TfR mRNA表达量分别下调了28.1%(P<0.01)和26.2%(P<0.05),并能显著下降富铁K562细胞铁的含量(P<0.05),更有效地抑制富铁K562细胞增殖。由此可见,二氢青蒿素能下调粒系白血病细胞TfR密度以及TfR蛋白和mRNA的表达,有效抑制常铁HL60和K562细胞的增殖,对富铁K562细胞增殖的抑制作用能进一步增强。
引用
收藏
页码:576 / 583
页数:8
相关论文
共 7 条
[1]   Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro [J].
Kim, SJ ;
Kim, MS ;
Lee, JW ;
Lee, CH ;
Yoo, H ;
Shin, SH ;
Park, MJ ;
Lee, SH .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (02) :129-135
[2]   Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds [J].
Lai, H ;
Sasaki, T ;
Singh, NP .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (05) :995-1007
[3]   Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells [J].
Lee, J ;
Zhou, HJ ;
Wu, XH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) :213-220
[4]   Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro [J].
Chen, HH ;
Zhou, HJ ;
Fan, X .
PHARMACOLOGICAL RESEARCH, 2003, 48 (03) :231-236
[5]  
mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether[J] . Thomas Efferth,Armin Olbrich,Rudolf Bauer.Biochemical Pharmacology . 2002 (4)
[6]   The anti-malarial artesunate is also active against cancer [J].
Efferth, T ;
Dunstan, H ;
Sauerbrey, A ;
Miyachi, H ;
Chitambar, CR .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (04) :767-773
[7]   Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat [J].
Moore, JC ;
Lai, H ;
Li, JR ;
Ren, RL ;
McDougall, JA ;
Singh, NP ;
Chou, CK .
CANCER LETTERS, 1995, 98 (01) :83-87